Skip to main content

Advertisement

Log in

Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose

Valutazione diagnostica post-chirurgica di pazienti con carcinoma tiroideo differenziato: confronto tra ecografia, scintigrafia con iodio-131 e PET con fluoro-18 fluorodesossiglucosio

  • Head and Neck Radiology Radiologia Del Capo e Del Collo
  • Published:
La radiologia medica Aims and scope Submit manuscript

An Erratum/Erratum to this article was published on 19 November 2009

Abstract

Purpose

The aim of this study was to compare the results of ultrasound (US), whole-body scintigraphy with iodine-131 (I-131 WBS) and positron emission tomography with fluorine-18 deoxyglucose (FDG-PET) in the follow-up of patients after thyroidectomy for differentiated thyroid carcinoma (DTC).

Materials and methods

Thirteen patients (3 men, 10 women) were evaluated by neck US, I-131 WBS and FDG-PET. In each patient six anatomical regions (right and left thyroid bed, right and left cervical region, right and left supraclavicular region) were investigated, for a total of 78 regions. Distant metastases were investigated by I-131 WBS and FDG-PET and considered separately in the analysis. Imaging findings were compared with the reference standards, such as fine-needle aspiration cytology (2), biopsy (4) or clinical-radiological studies (7).

Results

US, FDG-PET and I-131 WBS showed concordant negative results in most (70, 90%) of the anatomical sites considered. In one patient with left cervical lymph node metastasis, the imaging techniques showed concordant positive results (1%). In the remaining 7 regions (9%), the imaging results were discordant; in particular, tumour lesions, nodal metastases (4) and thyroid bed recurrences (3) were detected by US only (3), by US and I-131 WBS (1) and by FDG-PET only (3). With regard to distant metastases, FDG-PET and I-131 WBS yielded concordant negative results in the majority (77%) of patients (9); in one patient only were the two imaging techniques concordant in their positive result. In the last three patients, the results were discordant; in particular, distant metastases were detected by I-131 WBS only in two patients and by FDG-PET only in one patient.

Conclusions

Our work indicates a fundamental role for US in evaluation of the neck after surgery for DTC. WBS is useful to determine differentiation of tumour lesions, to identify thyroid remnants and to look for distant metastases. FDG-PET has an important role in cases of dedifferentiated thyroid carcinoma in which WBS and thyroglobulin measurements are unable to detect tumour lesions.

Riassunto

Obiettivo

Scopo dello studio è stato quello di confrontare i risultati ecografici, della scintigrafia “total-body” con I-131 (TB I-131) e della PET con fluorodesossiglucosio (FDG-PET) in un gruppo di pazienti con carcinoma tiroideo differenziato (CDT) sottoposti a terapia chirurgica.

Materiali e metodi

Tredici pazienti (3M, 10F) sono stati studiati con esame ecografico del collo (ECO), TB I-131 e FDG-PET. In ogni paziente sono state valutate 6 regioni anatomiche (loggia tiroidea destra e sinistra, regione latero-cervicale destra e sinistra, regione sovra-claveare destra e sinistra) per un totale di 78 regioni; le lesioni “a distanza” (LAD) sono state considerate come un ulteriore gruppo dell’analisi valutato in base al risultato della TB I-131 e della FDG-PET; i risultati sono stati confrontati con gli standard di riferimento quali dati citologici (n=2), istologici (n=4) o clinico-strumentali (n=7).

Risultati

L’ECO, la FDG-PET e il TB I-131 hanno mostrato una concordanza dei risultati in termini di negatività nella maggioranza (n=70; 90%) delle regioni anatomiche valutate; in un solo caso con metastasi linfonodali in regione latero-cervicale sinistra i risultati sono stati concordanti in termini di positività (1%). Nelle restanti 7 (9%) regioni, il risultato delle tre metodiche è stato discordante; in particolare, le lesioni tumorali, metastasi linfonodali (n=4) e ripresa di malattia in loggia tiroidea (n=3), sono state evidenziate dalla sola ECO (n=3), dall’ECO e dalla TB I-131 (n=1), esclusivamente dalla PET (n=3). Per le LAD, i risultati della FDG-PET e del TB I-131 sono stati concordanti nella maggioranza dei pazienti prevalentemente in termini di negatività (n=9); in un solo paziente è stata osservata concordanza dei risultati in termini di positività; nei restanti tre pazienti il risultato delle due tecniche è stato discordante; in particolare, in due pazienti solo l’esame TB I-131 ha mostrato le LAD, mentre in un paziente unicamente la FDG-PET dimostrava un reperto patologico.

Conclusioni

I risultati del nostro studio dimostrano un ruolo fondamentale dell’ECO per la valutazione delle diverse regioni anatomiche del collo in pazienti affetti da CDT durante il follow-up post-chirurgico allo scopo di identificare le lesioni tumorali loco-regionali; l’esame TB I-131, con dose terapeutica, resta altrettanto importante per la caratterizzazione della differenziazione tessutale delle lesioni, per la corretta valutazione e quantizzazione del residuo ghiandolare e per l’eventuale identificazione di LAD in pazienti con tumori differenziati. La FDG-PET mostra un suo ruolo in particolare nei casi di CDT che, nel corso del follow-up, sono andati incontro ad un processo di sdifferenziazione di eventuali lesioni recidivanti e, come tali, non diagnosticabili dal dosaggio della Tg e dal TB I-131.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References/Bibliografia

  1. Busnardo B, De Vito D (2000) The epidemiology and etiology of differentiated thyroid cancer. Biomed and Pharmacother 54:332–336

    Google Scholar 

  2. Mazzaferri EL (1999) An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 9:421–427

    Article  CAS  PubMed  Google Scholar 

  3. Barloch Z, Carayon P, Conte-Devolx B et al (2003) Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3–126

    Article  Google Scholar 

  4. Schlumberger M, Berg G (2004) Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol 150:105–112

    Article  CAS  PubMed  Google Scholar 

  5. Marqusee E, Benson CB, Frates MC et al (2000) Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 133: 696–700

    CAS  PubMed  Google Scholar 

  6. Tirlotano M, Crocetti U, D’Aloiso L et al (2003) Serum thyroglobulin and 131-I whole body scan after recombinant human TSH stimulation in the follow-up of low risk patients with differentiated thyroid cancer. The role of neck ultrasonography. Eur J Endocrinol 148:18–24

    Google Scholar 

  7. Clarke SEM. (1991) Radionuclide imaging in thyroid cancer. Diagnostic imaging 30:43–52

    Google Scholar 

  8. Less W, Mansberg R. (2002) The clinical effects of thyroid stunning after diagnostic whole body scanning with 185 MBq 131I. Eur J Nucl Med Mol Imaging 29:1421–1427

    Article  Google Scholar 

  9. Frasoldati A, Presenti M et al (2003) Diagnosis of neck recurrence in patients with differentiated thyroid carcinoma. Cancer 97: 90–96

    Article  PubMed  Google Scholar 

  10. Klain M, Maurea S, Cuocolo A et al (1996) Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans. Eur J Nucl Med 23:1568–1574

    Article  CAS  PubMed  Google Scholar 

  11. Altenvoerde G, Lerch H, Kuwert T (1998) Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans. Langenbecks Arch Surg 383:160–163

    CAS  PubMed  Google Scholar 

  12. Hegedüs L, Gerber H (2001) Thyroid ultrasound. Endocrinol Metab Clin North Am 30:339–360

    Article  PubMed  Google Scholar 

  13. Jeong H, Baek C, Baek H et al (2006) Integrated 18F-FDG-PET/CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma: comparison with ultrasound and contrast-enhanced CT. Clinical Endocrinology 65: 402–407

    Article  PubMed  Google Scholar 

  14. Palmedo H, Bucerius J, Jaeger U et al (2006) Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management. J Nucl Med 47: 616–624

    PubMed  Google Scholar 

  15. Heiko Schöder Henry WD Yeung (2004) Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med 34:180–197

    Article  Google Scholar 

  16. Mansi C, Moncayo R, Cuccurullo V et al (2004) Nuclear medicine in diagnosis, staging and follow-up of thyroid cancer. Q J Nucl Med Mol Imaging 48:82–89

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. Caleo.

Additional information

An erratum to this article can be found online at http://dx.doi.org/10.1007/s11547-009-0499-y.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caleo, O., Maurea, S., Klain, M. et al. Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose. Radiol med 113, 278–288 (2008). https://doi.org/10.1007/s11547-008-0243-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11547-008-0243-z

Keywords

Parole chiave

Navigation